Science & Research Staff Directory
CAMH is a leader in mental health research, with more than 120 scientists at the core of our research enterprise.
Meet Our Scientists
Dr. Alex Abramovich
Independent Scientist, Institute for Mental Health Policy Research, CAMH
alex.abramovich@camh.ca Read more about Dr. Alex AbramovichDr. Mahavir Agarwal
Clinician Scientist, Schizophrenia Division, CAMH
mahavir.agarwal@camh.ca Read more about Dr. Mahavir Agarwal
Dr. Ofer Agid
Clinician Scientist and Psychiatrist, Schizophrenia Division and Medical Leader, Home Intervention for Psychosis (HIP) team, CAMH
ofer.agid@camh.ca Read more about Dr. Ofer AgidDr. Stephanie Ameis
Clinician Scientist, Research Imaging Centre, Campbell Family Mental Health Research Institute and the Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health, CAMH
stephanie.ameis@camh.ca Read more about Dr. Stephanie Ameis
Dr. Brendan F. Andrade
Clinician Scientist, Child, Youth and Emerging Adult Program (CYEAP) and Margaret and Wallace McCain Centre for Child, Youth and Family Mental Health, CAMH
brendan.andrade@camh.ca Read more about Dr. Brendan F. Andrade
Dr. Mounira Banasr
Independent Scientist, Campbell Family Mental Health Research Institute, CAMH
mounira.banasr@camh.ca Read more about Dr. Mounira Banasr
Dr. Anne Bassett
Clinician Scientist, Campbell Family Mental Health Research Institute, CAMH
anne.bassett@utoronto.ca Read more about Dr. Anne BassettDr. Marco Battaglia
Associate Chief, Division of Child and Youth Psychiatry, CAMH
marco.battaglia@camh.ca Read more about Dr. Marco Battaglia
Dr. Daniel Blumberger
Clinician Scientist, Campbell Family Mental Health Research Institute, and Medical Head and Co-Director, Temerty Centre for Therapeutic Brain Intervention, CAMH
daniel.blumberger@camh.ca Read more about Dr. Daniel Blumberger
Dr. Isabelle Boileau
Scientist and Head, Addiction Imaging Research Group, Campbell Family Mental Health Research Institute, CAMH
isabelle.boileau@camh.ca Read more about Dr. Isabelle Boileau
CAMH Research Leads to Changes in Care
Clinicians implement recommendations to mitigate the effects of COVID-19 on people with schizophrenia and those with Alzheimer’s.
Read More
Suicide rate for people with schizophrenia spectrum disorders 170 times higher than the general population
Study identifies key risk factors
Read More
CAMH celebrates the launch of womenmind™
New philanthropic program will focus on closing the gender gap in mental health
Read More
We can email you tips and tools to help you manage your mental health during COVID-19.
Read More